Mike Brenner

@GBarnesMD @TODAYshow @alroker @isth @thrombosisday That’s great Geoff and definitely needed! Congrats!

I was honored to join Melanie Bloom on @TODAYshow with @alroker to raise awareness around blood clots. Thanks to @isth for leading the @thrombosisday campaign for 10 years! #MoveAgainstThrombosis

@konsiont @drpaulfriedman @MayoClinicCV @HRSonline Congrats Kostas!

@drpaulfriedman @MayoClinicCV Deeply grateful for this honor @HRSonline Thank you to mentors, mentees, colleagues and supportive environment at @MayoClinicCV

Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis Fantastic effort by the writing committee! @MKIttlesonMD @fsheikh22 @MathewMaurer @frederickruberg @vsanchorawala @JACCJournals: bit.ly/3HrCat8

The VA has long been a leader in #cvCoag care. See how rapidly they adopted a population health approach to #AntithromboticStewardship in this @CircOutcomes article. Thanks to @AHRQNews for funding! ahajournals.org/doi/10.1161/CI…

1/📌New Paper✏️ Prior work has shown convincingly that there are racial disparities in access to #LVAD and txp for pts with adv HF.   We sought to understand if inequities exist among pts receiving care at expert centers & if pt preferences for care would impact disparities

@GBarnesMD @UMich @UMichCardiology Congrats Geoff!

I'm honored to receive this notice of promotion to Associate Professor with tenure from @umich @UMichCardiology. I've been extremely fortunate to have amazing mentors and colleagues to guide my career development. Excited for the next chapter!

Neither MRA nor SGLT2i will meaningfully impact BP in HF patients. They are not they reason your pt is hypotensive & can be safely started/used even at lower BP. Start #GDMTWorks & save lives! @gcfmd @AndrewJSauer @mvaduganathan @DrNasrien @dranulala @SJGreene_md @UCSFIMChiefs

Amiodarone is an old anti-arrhythmic agent which means it can effect your LFTs, PFTs, and TFTs but not your NFTs because it's old and doesn't understand what they are.

@StephDwyer21 @beaverspharmd @ACCinTouch @accpcardprn @JaclynneGowen This was at my son’s preschool awhile back. I should have quizzed them. Haha!

@beaverspharmd @ACCinTouch @accpcardprn @JaclynneGowen bought me the same book! My daughter takes a deep breath on the lungs page and says “bum bum” for the heartbeat 😆

We start them young in this house. @ACCinTouch #ACCCVT @accpcardprn

@KNormanPharmD That’s fantastic!

it took us a year, but what it doesn’t tell you is that in that time this patient experienced homelessness and 🏥 for mental health and alcohol use disorder. customizing care and meeting patients where they’re at is just as important as how quickly we titrate meds #GDMTworks

@DaveDixonPharmD So many issues here

@muazzumshah @umichCVC @UMichCardiology @raklatch Congrats Muazzum! That’s great news!

a day late so i could soak it all in, but absolutely thrilled to continue @umichCVC for EP fellowship! beyond grateful for the family, friends, and mentors who have always been in my corner ❤️ #EPeeps #GoBlue @UMichCardiology @raklatch

@wbaker0621 @robdeedo @sandersonrx @DaveDixonPharmD @joeymattingly @FinlaySchultz I’m next on the list at my local liquor store for a bottle at state minimum. It’s only been almost 2 years on this list.

@robdeedo @sandersonrx @DaveDixonPharmD @joeymattingly @FinlaySchultz *gold

Happy Thanksgiving, @wbaker0621, @DaveDixonPharmD, @joeymattingly, @FinlaySchultz 🥃

SORT-AF RCT: 🩸Weight ⬇️ after AF ablation leads to signific ⬇️ in AF recurrence in pts with pers AF compared to pts with parox AF, 🩸but does not reduce AF burden in the entire study cohort #Europace @PrashSanders @Dominik_Linz @SABOURETCardio @DrMarthaGulati @rafavidalperez

Heart failure with preserved ejection fraction: a stepchild no more! | European Heart Journal | Oxford Academic academic.oup.com/eurheartj/arti…

Excited to see our paper in Annals today looking at blood pressure control regiments by adding multiple low dose meds vs. maxing dose then starting new meds. 🧵 acpjournals.org/doi/pdf/10.732…

In Press: Long-term Outcomes in Patients Treated with Flecainide for Atrial Fibrillation with Stable Coronary Artery Disease. sciencedirect.com/science/articl…

Excited to share our new #afib #screening decision model in @JAHA_AHA! Simulating 50m US individuals aged ≥65 years, we found 10 #afib screening strategies--including #wearables--were effective & minimized false positives. A fun @MGHHeartHealth & @mgh_ita collaboration. 🧵⬇️

The STROKESTOP trial and The LOOP study used different approaches to screen for #AtrialFibrillation, with the aim of initiating oral anticoagulation to prevent stroke and death nature.com/articles/s4156… @EmmaSvennberg, @johanengdahl2

#ESC 2021 Trials Summary #ESCCongress2021 #ESCCongress drive.google.com/file/d/1GMDXB7…